PUBLICACIÓN

Sacubitril-valsartan improves anemia of cardiorenal syndrome (Crs)

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Robles N.R., Campillejo R.D., Valladares J., de Vinuesa E.G., Villa J., Gervasini G.

2021 Cardiovascular and Hematological Agents in Medicinal Chemistry

Cardiology and Cardiovascular Medicine (Q3), Hematology (Q3), Medicine (miscellaneous) (Q3), Pharmacology (Q3)

SJR: 0.409


CITAS

5

DOI

10.2174/1871525718666200506095537

EID

2-s2.0-85102942155

ISSN

1871-5257

EISSN

1875-6182

BIBTEX

@article{Robles_2021, doi = {10.2174/1871525718666200506095537}, url = {https://doi.org/10.2174%2F1871525718666200506095537}, year = 2021, month = {may}, publisher = {Bentham Science Publishers Ltd.}, volume = {19}, number = {1}, pages = {93--97}, author = {Nicol{\'{a}}s R. Robles and Rosa D. Campillejo and Julian Valladares and Elena G. de Vinuesa and Juan Villa and Guillermo Gervasini}, title = {Sacubitril-Valsartan Improves Anemia of Cardiorenal Syndrome ({CRS})}, journal = {Cardiovascular {\&} Hematological Agents in Medicinal Chemistry} }


AUTORES DE LA UEX